SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
Ciprofloxacin
Journals
6
1
Bioorganic chemistry
2
Environmental science and pollution research international
3
Carbohydrate polymers
4
Journal of hazardous materials
5
turkish journal of chemistry
6
environmental toxicology
Research Groups
0
No Research Group Connected
Bibliographies
71
1
Determination of N-acetylcysteine in the presence of ciprofloxacin or levofloxacin in microparticulate dry powder inhalers
2
Embryonic development, locomotor behavior, biochemical, and epigenetic effects of the pharmaceutical drugs paracetamol and ciprofloxacin in larvae and embryos of Danio rerio when exposed to environmental realistic levels of both drugs.
3
Prepartion and application of novel blast furnace dust based catalytic-ceramic-filler in electrolysis assisted catalytic micro-electrolysis system for ciprofloxacin wastewater treatment.
4
Design, synthesis and molecular docking of new N-4-piperazinyl ciprofloxacin-triazole hybrids with potential antimicrobial activity.
5
pharmacokinetic profile of enrofloxacin and its metabolite ciprofloxacin in asian house geckos (hemidactylus frenatus) after single-dose oral administration of enrofloxacin
6
prescripción de ciprofloxacino por vía parenteral en pacientes ingresados en los servicios de medicina interna y caumatología de un hospital general
7
an evaluation of the antimicrobial synergy of garlic (allium sativum) and utazi (gongronema latifolium) on escherichia coli and staphylococcus aureus
8
role of 5´-amp-activated protein kinase activators in regulating nuclear factor kappa b signaling
9
ciprofloxacin induced bullous fixed drug reaction: three case reports
10
clinical resistance of staphylococcus keratitis to ciprofloxacin monotherapy.
11
synthesis, crystal structure, stacking effect and antibacterial studies of a novel quaternary copper (ii) complex with quinolone
12
oral manifestations of hiv
13
comparison of the effect of co-trimoxazole and co-trimoxazole plus ciprofloxacin in urinary tract infection prophylaxis in kidney transplant patients
14
Evolution and transmission of a conjugative plasmid encoding both ciprofloxacin and ceftriaxone resistance in Salmonella.
15
Synthesis, identification and application of the novel metal-organic framework Fe<inf>3</inf>O<inf>4</inf>@PAA@ZIF-8 for the drug delivery of ciprofloxacin and investigation of antibacterial activity
16
Determination of N-acetylcysteine in the presence of ciprofloxacin or levofloxacin in microparticulate dry powder inhalers
17
Expansion of Salmonella Typhi clonal lineages with ampicillin resistance and reduced ciprofloxacin susceptibility in Eastern China
18
In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates
19
Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa
20
The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA
21
Expansion of Salmonella Typhi clonal lineages with ampicillin resistance and reduced ciprofloxacin susceptibility in Eastern China
22
In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates
23
Expansion of Salmonella Typhi clonal lineages with ampicillin resistance and reduced ciprofloxacin susceptibility in Eastern China
24
In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates
25
Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa
26
The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA
27
Ecotoxicological effects and accumulation of ciprofloxacin in Eichhornia crassipes under hydroponic conditions.
28
Effects of green synthesis, magnetization, and regeneration on ciprofloxacin removal by bimetallic nZVI/Cu composites and insights of degradation mechanism.
29
Experimental and theoretical aspects of biochar-supported nanoscale zero-valent iron activating H<inf>2</inf>O<inf>2</inf> for ciprofloxacin removal from aqueous solution
30
Ultrathin BiOCl/nitrogen-doped graphene quantum dots composites with strong adsorption and effective photocatalytic activity for the degradation of antibiotic ciprofloxacin
31
The BiOCl/diatomite composites for rapid photocatalytic degradation of ciprofloxacin: Efficiency, toxicity evaluation, mechanisms and pathways
32
Facile synthesis of ZnFeO@RGO nanocomposites towards photocatalytic ciprofloxacin degradation and H energy production.
33
Synthesis, identification and application of the novel metal-organic framework Fe<inf>3</inf>O<inf>4</inf>@PAA@ZIF-8 for the drug delivery of ciprofloxacin and investigation of antibacterial activity
34
Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation
35
Ciprofloxacin/Gatifloxacin-1,2,3-triazole-isatin Hybrids and Their In Vitro Anticancer Activity
36
Design, synthesis and antibacterial evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl] Ciprofloxacin-(4-Methyl-3-Aryl)-1,2,4-Triazole-5(4H)-Thione Hybrids
37
Design, Synthesis and Antibacterial Evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl]ciprofloxacin-1,2,4-triazole-5(4H)-thione Hybrids
38
Persulfate activation by sulfide-modified nanoscale iron supported by biochar (S-nZVI/BC) for degradation of ciprofloxacin
39
New matrix certified reference material for accurate measurement of ciprofloxacin residue in egg.
40
Porous-CdS/Cu<inf>2</inf>O/graphitic-C<inf>3</inf>N<inf>4</inf> dual p-n junctions as highly efficient photo/catalysts for degrading ciprofloxacin and generating hydrogen using solar energy
41
Ciprofloxacin-Resistant Serovar Kentucky ST198 in Broiler Chicken Supply Chain and Patients, China, 2010-2016.
42
Photo-induced degradation of bio-toxic Ciprofloxacin using the porous 3D hybrid architecture of an atomically thin sulfur-doped g-CN/ZnO nanosheet.
43
Azithromycin and ciprofloxacin have a chloroquine-like effect on respiratory epithelial cells.
44
Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit
45
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
46
Effect of Delaying Treatment on Efficacy of Ciprofloxacin and Levofloxacin in the African Green Monkey Model of Pneumonic Plague
47
Development of ciprofloxacin and nano-hydroxyapatite dual-loaded polyurethane scaffolds for simultaneous treatment of bone defects and osteomyelitis
48
Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds
49
Ciprofloxacin for the Treatment of Uncomplicated Gonorrhea Infection in Adolescents: Does the Benefit Outweigh the Risk?
50
Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.
51
Ciprofloxacin-loaded bioadhesive hydrogels for ocular applications
52
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.
53
Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study
54
Investigation into the selection frequency of resistant mutants and the bacterial kill rate by levofloxacin and ciprofloxacin in non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients
55
Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios
56
Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation
57
Structural elucidation of Levofloxacin and Ciprofloxacin using density functional theory and Raman spectroscopy with inexpensive lab-built setup
58
association between mutations in gyra and parc genes of acinetobacter baumannii clinical isolates and ciprofloxacin resistance
59
the study of synergistic effects of n.butanolic cyclamen coum extract and ciprofloxacin on inhibition of pseudomonas aeruginosa biofilm formation
60
herb-drug interaction: effects of relinqing® granule on the pharmacokinetics of ciprofloxacin, sulfamethoxazole, and trimethoprim in rats
61
escherichia coli resistente a ciprofloxacina em pacientes internados em hospital universitário de manaus, 2015
62
severe rhabdomyolysis associated with simvastatin and role of ciprofloxacin and amlodipine coadministration
63
spectroscopy and speciation studies on the interactions of aluminum (iii) with ciprofloxacin and β-nicotinamide adenine dinucleotide phosphate in aqueous solutions
64
transcriptome profiling reveals interplay of multifaceted stress response in escherichia coli on exposure to glutathione and ciprofloxacin
65
ciprofloxacin controlled-solid lipid nanoparticles: characterization, in vitro release, and antibacterial activity assessment
66
Occurrence of Ceftriaxone Resistance in Ciprofloxacin-Resistant Salmonella enterica Serotype Choleraesuis Isolates Causing Recurrent Infection
67
High Prevalence of Ciprofloxacin-Resistant Neisseria gonorrhoeae in Northern Taiwan
68
A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group
69
Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial
70
Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status
71
Comparison of Ciprofloxacin (7 Days) and Trimethoprim-Sulfamethoxazole (14 Days) for Acute Uncomplicated Pyelonephritis in Women: A Randomized Trial